RCM
IONS icon

Rotella Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Rotella Capital Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-4,800
Closed -$297K – 127
2015
Q4 		$297K Buy
+4,800
New +$259K 0.27% 192

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Rotella Capital Management's IONS Position: Q1 2016 in Review

Rotella Capital Management sold out of Ionis Pharmaceuticals (IONS) in Q1 2016, closing a stake of 4,800 shares — an estimated $297K sold.

Rotella Capital Management first reported a position in IONS in Q4 2015 and held it in 1 quarter. The position peaked at $297K in Q4 2015. 315 funds tracked by Wall St. Rank hold IONS as of Q1 2016.

  • Rotella Capital Management reported no remaining Ionis Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Rotella Capital Management sold 4,800 Ionis Pharmaceuticals shares in Q1 2016, an estimated $297K.
  • Rotella Capital Management first reported a position in Ionis Pharmaceuticals in Q4 2015 and held it in 1 quarter.
  • Rotella Capital Management's Ionis Pharmaceuticals position peaked at $297K in Q4 2015.
  • 315 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2016.

Based on Rotella Capital Management's 13F filing for Q1 2016, filed 13 May 2016.